TeraRecon (a ConcertAI company)

Durham, NC  All United States companies → Founded 1997
Imaging AI Specialist
Neurology Neurosurgery Radiology
Neurology AI
Acquired — $62.5M (prior to acquisition)

Products

Neuro.Al Algorithm
TeraRecon (a ConcertAI company)
Neurology AI
TeraRecon's Neuro.Al Algorithm is an FDA-cleared AI-powered image processing software for advanced brain imaging analysis, providing insights into brain perfusion and vascular assessment from CT and MRI data.

See all 1 product →

About TeraRecon (a ConcertAI company)

TeraRecon, a ConcertAI company, is a leading provider of advanced visualization (AV) and artificial intelligence (AI) solutions for medical imaging. Founded in 1997 by Japanese radiologists, the company has evolved to offer technology-driven systems and solutions based on patented image processing technologies. Their mission is to continuously innovate to provide solutions that empower physicians with enhanced access to medical images and robust clinical decision support tools, thereby impacting clinical care across health systems.

For physicians, TeraRecon delivers AI-empowered AV and clinical workflow solutions across multiple specialties, including radiology, oncology, cardiology, neurology, and vascular surgery. Solutions such as TeraRecon AV™ and TeraRecon DETECT™ are designed to improve diagnostic precision, streamline processes, and enhance patient care through AI-driven automation and specialized clinical tools. These solutions are vendor-neutral, integrating seamlessly with existing PACS systems to create a unified and simplified clinical workflow, which boosts efficiency and provides actionable, physician-guided insights. Additionally, TeraRecon offers AI-assisted specialty clinical workflow solutions like TeraRecon Neuro, specifically developed for disease screening and care activation in neurovascular emergencies, allowing physicians to interact with AI algorithms to refine outputs and facilitate coordinated care.

Focus Areas

Advanced Visualization AI-driven Medical Imaging Radiology Cardiology Oncology Neurology Vascular Surgery Image Post-Processing Clinical Decision Support Workflow Automation Enterprise Imaging AI Reimbursement Optimization

Business Intelligence

Key InvestorsMobile Internet Capital, PENTAX Medical, SymphonyAI, Fujifilm
Partnerships3DR Labs, DeepHealth (RadNet subsidiary), Lucida Medical, INFINITT Europe, Mirada Medical, Optellum, Change Healthcare
AcquisitionsMcCoy Medical Technologies (2017), Acquired by SymphonyAI Group (2020), Integrated into ConcertAI (2021)
TechnologyCloud-native, AI-driven automation, advanced 3D/4D imaging, enterprise-wide medical imaging platform, Eureka Clinical AI platform, TeraRecon AV (formerly Intuition), TeraRecon DETECT, SaaS model, integrates with PACS/VNA
FDA Clearances14 FDA 510(k) cleared radiology devices (including Northstar AI Results Explorer as Class I exempt and TeraRecon Aorta.CT as Class II) cleared products (estimated)

What Physicians Need to Know

Advanced Visualization (AV)
TeraRecon AVu2122 (formerly Intuitionu2122) is a leading enterprise-wide platform providing AI-driven 3D and 4D imaging capabilities. It offers specialized workflows for cardiology, oncology, neurology, and vascular surgery, including advanced structural heart enhancements (TTVR, TMVR, LAA), zero-click 3D batching, and enhanced image quality.
AI-driven Medical Imaging
With an AI-first approach, TeraRecon leverages its Eureka Clinical AI Platform as an interoperability framework for AI. Key offerings include TeraRecon DETECTu2122 for optimizing AI imaging reimbursement workflows and a wide range of AI-enabled biomarkers such as FFR-CT, plaque analysis, MR prostate, bone density, and lung cancer screening. It also provides AI-powered automation for reporting and workflow.
Specialty-Specific Workflows
TeraRecon provides tailored solutions across numerous specialties: n* **Cardiology:** Comprehensive tools for CT and MR cardiac imaging (including T1/T2/T2* mapping, 2D flow, strain analysis, perfusion quantification), TAVR, TTVR, Mitral Valve/TMVR, LAA, and calcium scoring.n* **Neurology:** Solutions for stroke care, timely automation, optimized neuro disorder workflows, brain perfusion, maxillofacial imaging, and an AI-assisted Neuro Suite for neurovascular emergencies.n* **Oncology:** Precise imaging workflows for CT and MR body imaging, PET/CT Fusion, liver segmentation, lesion tracking, and AI-driven lung nodule screening and detection.n* **Radiology & Vascular Surgery:** General and specialized tools for image post-processing, volumetric navigation, and intervention planning.
Clinical Decision Support
The platform delivers AI-driven insights, real-time business intelligence dashboards, and mobile alerts to confirm AI findings. Its interactive AI results explorer provides an all-new approach to incorporating clinical imaging insights into point-of-care workflows.
Workflow Automation
TeraRecon streamlines diagnostic workflows through automated data extraction, analysis, and report generation. Features include prior authorization management, zero-click 3D batching, and automated functions like precalculating centerlines, applying image filters, removing bones, and identifying anatomical landmarks.
Enterprise Imaging
TeraRecon unifies advanced imaging needs on a single, powerful platform, enabling enterprise-wide AI-driven imaging interpretation. It supports numerous modalities and concurrent users from a single virtual server, consolidating and aligning technologies across the health system.
AI Reimbursement Optimization
TeraRecon DETECTu2122 is specifically designed to identify opportunities to optimize reimbursement for AI imaging biomarkers. It streamlines the prior authorization process, ensures compliance with reimbursement criteria, and supports efforts to reduce costly claim denials by pre-populating standardized, reimbursement-ready reports.
Physician Tip

For physicians, TeraRecon stands out by offering tools that lead to **more confident diagnoses** through clinically meaningful AI-enabled biomarkers and advanced 3D/4D imaging. The platform significantly **reduces interpretation time and clinical burden** by leveraging AI-powered automation for tasks like reporting, 3D batching, and workflow streamlining, allowing more time to **focus on patient care**. It enhances **pre-procedure planning** with comprehensive toolkits for complex interventions and fosters **improved collaboration** through a single, cohesive AI-enabled AV solution, image sharing across specialties, and mobile access to patient lists and AI findings. Physicians gain access to a **broad range of AI tools** via an open platform that integrates various algorithms, providing comprehensive, **real-time insights** through actionable dashboards. The emphasis on **standardized and consistent workflows** helps reduce variation in clinical outcomes, ultimately improving patient management and care delivery.

TeraRecon's solutions are designed for **seamless integration** with existing Radiology and Cardiology Picture Archiving and Communication Systems (PACS). The platform offers **full support and interoperability** with PACS, Vendor Neutral Archives (VNA), Radiology Information Systems (RIS), Electronic Medical Records (EMR), DICOM, and HL7 reporting systems and frameworks. They actively partner with leading global PACS companies (e.g., INFINITT Europe, Change Healthcare) to embed their tools deeply into interpretation workflows. A key differentiator is the **Eureka Clinical AI Platform's openness to third-party AI algorithms**, allowing consolidated management and orchestration of diverse AI solutions. EMR-embedded technology also facilitates secure image uploads.

Products by TeraRecon (a ConcertAI company)

1 product in the directory

Neuro.Al Algorithm
TeraRecon (a ConcertAI company)
Neurology AI
TeraRecon's Neuro.Al Algorithm is an FDA-cleared AI-powered image processing software for advanced brain imaging analysis, providing insights into brain perfusion and vascular assessment from CT and MRI data.

What the Web Says

TeraRecon, a ConcertAI company since 2021, specializes in advanced visualization and AI solutions for medical imaging, particularly in radiology, cardiology, and neurology. Their platforms, Intuition and Eureka Clinical AI, aim to enhance diagnostic accuracy and efficiency by providing tools for 3D and 4D post-processing and integrating AI algorithms. Reviews indicate that the company's products are highly regarded for their advanced capabilities and ease of use, while employer reviews for ConcertAI show a mixed but generally positive sentiment regarding workplace culture and flexibility, though some concerns exist about management and career advancement.

Overall: Mixed

Strengths

  • Advanced visualization and AI capabilities for medical imaging
  • Intuition platform is a market share leader in radiology and cardiology advanced visualization
  • Supports many modalities and a high number of concurrent users from a single virtual server
  • Ease of use and intuitive interface
  • Streamlines post-processing and boosts productivity across various imaging techniques
  • Good work-life balance and supportive environment (for ConcertAI employees)

Limitations

  • Some employees report poor pay scales compared to other companies and abundant layoffs for historical employees at ConcertAI
  • Concerns about management stability, internal promotions being political, and favoritism at ConcertAI
  • Lack of product growth and constant management changes have stifled growth and upward mobility for some TeraRecon employees
  • Communication issues between higher management and employees at ConcertAI
  • Some Reddit users mention that 3D rendering can be time-consuming and not always diagnostically valuable beyond planar reformats
  • One older review for TeraRecon mentioned poor ethics and management, though this was prior to the ConcertAI acquisition

Based on reviews from: Elion Health, SourceForge, The Silicon Review, Great Place To Worku00ae, TeraRecon Official Website, About TeraRecon Official Website, Indeed.com (ConcertAI), Indeed.com (TeraRecon), ZipRecruiter, Reddit

Last updated: 2026-07-19

Videos

News, demos, and interviews about TeraRecon (a ConcertAI company).

Loading videos...

Videos load interactively. If none appear, search YouTube for TeraRecon (a ConcertAI company) →

View all on YouTube

Press & Coverage

Business Wire
ConcertAI Introduces TeraRecon AVu2122, Advancing AI-Powered Medical Imaging with New Structural Heart and SaaS Capabilities
ConcertAI's TeraRecon announced TeraRecon AVu2122, an advanced medical imaging visualization solution that uses AI-driven automation and new specialized clinical tools to enhance diagnostic precision and streamline processes. This solution offers advanced structural heart imaging simulations and integrates with third-party 3D segmentation models.
2025-11
Business Wire
ConcertAI's TeraRecon DETECTu2122 Helps Identify Opportunities to Optimize AI Imaging Reimbursement Workflows, Expanding Patient Access to the Most Advanced Care
ConcertAI's TeraRecon launched TeraRecon DETECTu2122, an AI-powered platform designed to optimize reimbursement for multiple imaging biomarkers. This solution aims to improve patient screening, reduce clinician administrative time, and streamline operational workflows for hospitals.
2025-11
TeraRecon
ConcertAI's TeraRecon Surpasses 2,000 Global Customers, Accelerating Cloud-First SaaS Transformation to Further Unlock Productivity for Healthcare Providers
ConcertAI's TeraRecon announced it has surpassed 2,000 global customers, driven by the adoption of AI-enabled workflows and strategic partnerships. This milestone highlights the company's progress in its cloud-first SaaS transformation to enhance productivity for healthcare providers.
2025-09
Business Wire
ConcertAI's TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers
ConcertAI's TeraRecon and 3DR Labs expanded their partnership to enhance the delivery of AI-enabled image post-processing clinical services. This collaboration aims to integrate cloud-based, AI-powered technologies to streamline clinical services and scale operations in advanced imaging.
2025-03
TeraRecon
ConcertAI's TeraRecon Launches Three New Care Suites, Life Sciences Platform, and Strategic Partnerships at #ECR24
ConcertAI's TeraRecon launched new Clinical AI care suites for Cardiology, Pulmonology, and Neurology, along with a multi-modal predictive and Gen AI platform for research and clinical model development. The announcement also included new strategic partnerships.
2024-02
Imaging Technology News
ConcertAI's TeraRecon, Integrates Clinical and Generative AI, Supporting Clinical Research and Advancing Clinical Care Solutions at RSNA23
ConcertAI's TeraRecon unveiled new capabilities in advanced visualization, AI, and an expanded AI partner ecosystem at RSNA23 to enhance research and support complex clinical study workflows. They also launched a multi-modal AI platform for clinical research, trials, and deployment of AI models for prospective clinical validation.
2023-11
Diagnostic and Interventional Cardiology
ConcertAI's TeraRecon Showcases New Clinical and AI Solutions Designed to Enhance Treatment Planning for Structural Heart Patients at TCT 2023
ConcertAI's TeraRecon showcased its latest innovations and cardiology solutions at TCT 2023, focusing on enhancing treatment planning for structural heart patients. This included new robust cardiovascular advanced visualization functionality and enhancements to streamline cardiac coronary imaging.
2023-10
TeraRecon
TeraRecon Receives First-of-Kind FDA Determination
TeraRecon announced it successfully completed an FDA regulatory review of its Northstaru2122 AI Results Explorer, a first-of-its-kind technology in medical imaging. This determination reinforces the company's commitment to regulatory and quality standards in medical imaging AI.
2019-06

Frequently Asked Questions

TeraRecon's advanced visualization (AV) and AI platform, including TeraRecon AVu2122 (formerly Intuitionu2122) and Eureka Clinical AI, provides AI-driven automations and advanced 3D/4D imaging capabilities tailored for multiple specialties. It offers specialized workflows for areas such as cardiology, oncology, neurology, radiology, and vascular surgery, enhancing diagnostic precision, treatment planning, and efficiency across the enterprise.
TeraRecon offers solutions like the Eureka Clinical AI Platform, which integrates multiple AI algorithms to streamline workflows and provide clinical decision support, and TeraRecon DETECTu2122, designed to automate insights and improve patient care by driving the adoption of reimbursable AI biomarkers. These platforms accelerate clinical workflows with AI-driven efficiency gains and allow clinicians to interact with and validate AI findings.
TeraRecon addresses AI reimbursement concerns through its TeraRecon DETECTu2122 platform, an AI-powered solution that helps healthcare providers identify opportunities to optimize reimbursement for AI biomarkers. It assists in streamlining prior authorization, managing pre-authorization, and supporting efforts to reduce claim denials, thereby enhancing the financial viability of adopting AI in imaging.
TeraRecon prioritizes data security and privacy, with its cloud-based SaaS model ensuring enhanced compliance with regulations such as HIPAA, GDPR, and SOC2 through automatic software updates and security patches. The company also self-certifies to the EU-U.S. Data Privacy Framework and implements strict internal policies for handling and de-identifying Protected Health Information (PHI) and Personally Identifiable Information (PII).
TeraRecon's Eureka Clinical AI platform is vendor-agnostic, designed to seamlessly integrate with existing enterprise imaging systems, including PACS, RIS, and EMRs, using DICOM and HL7 communication standards. This approach ensures interoperability, allows for the consolidation of various AI solutions, and supports both third-party and in-house developed AI algorithms within a unified workflow.
As a ConcertAI company, TeraRecon's long-term vision focuses on accelerating the deployment of AI in clinical practice and expanding precision oncology research by integrating medical imaging data with electronic medical records and genomic data. The shift to a cloud-based SaaS model ensures continuous product development, immediate access to the latest AI-enabled tools, and sustained support for its global customer base, reinforcing company stability.
TeraRecon has transitioned to a predictable subscription-based pricing model for its cloud-based SaaS offerings, including TeraRecon AVu2122 and Eureka Clinical AI. This model aims to lower the total cost of ownership by reducing the need for extensive on-premises infrastructure and providing continuous access to software updates, security patches, and an expanding suite of AI-enabled applications.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]

Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.